HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: ard.2005.041079v1 65/3/366    most recent Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Linn-Rasker, S P Articles by Huizinga, T W J Search for Related Content PubMed PubMed Citation Articles by Linn-Rasker, S P Articles by Huizinga, T W J

Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles

¹ Department of Rheumatology, Leiden University Medical Centre, Leiden, Netherlands
² Departments of Rheumatology and Epidemiology, Leiden University Medical Centre
³ Department of Immunohaematology and Blood transfusion, Leiden University Medical Centre
⁴ Department of Medical Statistics, Leiden University Medical Centre

Correspondence to:
Correspondence to:
Dr Annette H H van der Helm-van Mil
Department of Rheumatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, Netherlands; AvdHelm{at}lumc.nl

Objectives: To study the gene–environment interaction of tobacco exposure and shared epitope on autoantibodies in patients with rheumatoid arthritis and undifferentiated arthritis.

Methods: From incident cases of arthritis (n = 1305), patients who did not fulfil any classification criteria (undifferentiated arthritis (n = 486)) and those who fulfilled the American College of Rheumatology criteria for rheumatoid arthritis (n = 407) were identified. IgM rheumatoid factor (RF), anti-cyclic-citrullinated peptide (CCP) antibodies, and HLA-DRB1 alleles were determined.

Results: In rheumatoid arthritis, an interaction was found between tobacco exposure and shared epitope for the presence of anti-CCP antibodies, as the odds ratio for anti-CCP antibodies in patients having both tobacco exposure (TE) and shared epitope (SE) was higher than the summed odds ratios of patients having only tobacco exposure or shared epitope (odds ratios: TE+/SE–, 1.07; TE–/SE+, 2.49; and TE+/SE+, 5.27—all relative to TE–/SE–). A similar effect was found for RF, but stratification showed that the interaction primarily associated with the anti-CCP antibody response. In patients with undifferentiated arthritis at two weeks, or with persistent undifferentiated arthritis after one year, no interaction between tobacco exposure and shared epitope was observed for the presence of autoantibodies.

Conclusions: Tobacco exposure increases the risk factor for anti-CCP antibodies only in shared epitope positive patients with rheumatoid arthritis. The gene–environment interaction between smoking and shared epitope leading to autoantibodies is specific for rheumatoid arthritis and is not observed in undifferentiated arthritis.

Keywords: rheumatoid arthritis; anti-CCP antibodies; rheumatoid factor; smoking; shared epitope

This article has been cited by other articles:

				S. Kobayashi, H. Okamoto, T. Iwamoto, Y. Toyama, T. Tomatsu, H. Yamanaka, and S. Momohara A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis Rheumatology, September 1, 2008; 47(9): 1317 - 1322. [Abstract] [Full Text] [PDF]

				M.-K. Koivula, E. Savolainen, O. Kaipiainen-Seppanen, H. Kautiainen, R. Luosujarvi, M. Hakala, and J. Risteli Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series Rheumatology, May 1, 2008; 47(5): 656 - 659. [Abstract] [Full Text] [PDF]

				L Michou, V H Teixeira, C Pierlot, S Lasbleiz, T Bardin, P Dieude, B Prum, F Cornelis, and E Petit-Teixeira Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis Ann Rheum Dis, April 1, 2008; 67(4): 466 - 470. [Abstract] [Full Text] [PDF]

				E W Karlson, L B Chibnik, J Cui, R M Plenge, R J Glass, N E Maher, A Parker, R Roubenoff, E Izmailova, J S Coblyn, et al. Associations between Human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study Ann Rheum Dis, March 1, 2008; 67(3): 358 - 363. [Abstract] [Full Text] [PDF]

				A Finckh, S Dehler, K H Costenbader, C Gabay, and on behalf of the Swiss Clinical Quality Management Cigarette smoking and radiographic progression in rheumatoid arthritis Ann Rheum Dis, August 1, 2007; 66(8): 1066 - 1071. [Abstract] [Full Text] [PDF]

				D. P. M. Symmons Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor? Rheumatology, May 1, 2007; 46(5): 725 - 726. [Full Text] [PDF]

				B. Vander Cruyssen, I. E A Hoffman, I. Peene, A. Union, H. Mielants, L. Meheus, and F. De Keyser Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope Ann Rheum Dis, March 1, 2007; 66(3): 364 - 369. [Abstract] [Full Text] [PDF]

eLetters: